Eric Wyffels
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Eric Wyffels has a total of 126 co-authors. Here are the top co-authors by number of shared publications:
Bernard De Bruyne
Cardiovascular Center Aalst OLV‐Clinic Aalst Belgium
5 shared publicationsCarlos Collet
Cardiovascular Center Aalst, OLV‐Hospital Aalst Belgium
5 shared publicationsDario Tino Bertolone
Cardiovascular Center Aalst, OLV‐Hospital Aalst Belgium
5 shared publicationsJozef Bartunek
Cardiovascular Research Center Aalst
5 shared publicationsEmanuele Barbato
“Sapienza” University of Rome
4 shared publications- Emanuele Gallinoro
Cardiology Unit, Sant'Andrea University Hospital, Rome, Italy
4 shared publications
Latest Publications
- Open Access
- 1 November 2026
- Published by American Physiological Society in American Journal of Physiology-Heart and Circulatory Physiology
- Vol. 331 (5) , H1498-H1508
Restoration of frequency-dependent myocardial reserve after TAVI in severe aortic stenosis: an invasive hemodynamic study
This study provides direct invasive human evidence that frequency-dependent myocardial reserve is acutely restored after TAVI in severe aortic stenosis. Controlled atrial pacing revealed blunted force-frequency and relaxation-frequency responses before valve replacement, despite preserved ejection fraction, with rapid recovery after afterload relief. These findings show that impaired myocardial reserve in pressure-overload remodeling is functionally reversible and tightly linked to loading conditions.
- 1 November 2026
- Published by American Physiological Society in American Journal of Physiology-Heart and Circulatory Physiology
- Vol. 331 (5) , H1498-H1508
Open AccessRestoration of frequency-dependent myocardial reserve after TAVI in severe aortic stenosis: an invasive hemodynamic study
This study provides direct invasive human evidence that frequency-dependent myocardial reserve is acutely restored after TAVI in severe aortic stenosis. Controlled atrial pacing revealed blunted force-frequency and relaxation-frequency responses before valve replacement, despite preserved ejection fraction, with rapid recovery after afterload relief. These findings show that impaired myocardial reserve in pressure-overload remodeling is functionally reversible and tightly linked to loading conditions.
- Open Access
- 1 March 2026
- Published by Wolters Kluwer Health in Circulation: Cardiovascular Interventions
- Vol. 19 (3) , e015851
Influence of Pullback Pressure Gradient on Residual Angina at One Year
BACKGROUND: The pullback pressure gradient (PPG) is a novel physiological metric that quantifies coronary artery disease patterns as focal or diffuse on a scale from 0 to 1. This study assessed the relationship between PPG and residual angina at 1 year. METHODS: PPG Global is a prospective, investigator-initiated, single-arm, multicenter study that enrolled patients with at least 1 lesion with a fractional flow reserve ≤0.80 intended to be treated with percutaneous coronary intervention. After the PPG calculation, physicians could revise treatment assignment to medical therapy or coronary artery bypass graft surgery instead of percutaneous coronary intervention. Focal and diffuse disease were defined based on the median PPG value of 0.62. Patient-reported outcomes were assessed using the Seattle Angina Questionnaire at baseline and 1-year follow-up. RESULTS: The study included 947 patients with PPG and the Seattle Angina Questionnaire at 1 year. The mean age was 67.6±10.2 years, 24% were female, and 29% had diabetes. At 1 year, patients with focal coronary artery disease reported less angina than those with diffuse disease (Seattle Angina Questionnaire angina frequency score, 95.3±9.9 versus 92.5±15.0; P =0.006). PPG was independently associated with improvement in angina ( P =0.017). CONCLUSIONS: In patients with flow-limiting coronary artery disease, a focal disease pattern defined by high PPG was associated with greater symptomatic relief at 1 year compared with diffuse disease (low PPG). By capturing the underlying pathophysiologic distribution of epicardial disease and its relation to post-treatment symptom relief, PPG may support a more tailored revascularization decision-making and percutaneous coronary intervention strategy.
- 1 March 2026
- Published by Wolters Kluwer Health in Circulation: Cardiovascular Interventions
- Vol. 19 (3) , e015851
Open AccessInfluence of Pullback Pressure Gradient on Residual Angina at One Year
BACKGROUND: The pullback pressure gradient (PPG) is a novel physiological metric that quantifies coronary artery disease patterns as focal or diffuse on a scale from 0 to 1. This study assessed the relationship between PPG and residual angina at 1 year. METHODS: PPG Global is a prospective, investigator-initiated, single-arm, multicenter study that enrolled patients with at least 1 lesion with a fractional flow reserve ≤0.80 intended to be treated with percutaneous coronary intervention. After the PPG calculation, physicians could revise treatment assignment to medical therapy or coronary artery bypass graft surgery instead of percutaneous coronary intervention. Focal and diffuse disease were defined based on the median PPG value of 0.62. Patient-reported outcomes were assessed using the Seattle Angina Questionnaire at baseline and 1-year follow-up. RESULTS: The study included 947 patients with PPG and the Seattle Angina Questionnaire at 1 year. The mean age was 67.6±10.2 years, 24% were female, and 29% had diabetes. At 1 year, patients with focal coronary artery disease reported less angina than those with diffuse disease (Seattle Angina Questionnaire angina frequency score, 95.3±9.9 versus 92.5±15.0; P =0.006). PPG was independently associated with improvement in angina ( P =0.017). CONCLUSIONS: In patients with flow-limiting coronary artery disease, a focal disease pattern defined by high PPG was associated with greater symptomatic relief at 1 year compared with diffuse disease (low PPG). By capturing the underlying pathophysiologic distribution of epicardial disease and its relation to post-treatment symptom relief, PPG may support a more tailored revascularization decision-making and percutaneous coronary intervention strategy.
- 4 May 2025
- Published by Taylor & Francis in Acta Clinica Belgica
- Vol. 80 (3) , 35-43
Barriers to guideline implementation in intermediate- and high-risk Pulmonary Embolism: insights from a real-world cohort study
Pulmonary embolism (PE) presents significant challenges due to its wide clinical spectrum, associated right ventricular failure, and high mortality rates. Despite guideline recommendations for systemic thrombolysis in high-risk PE, its implementation remains suboptimal due to safety concerns. This study investigates barriers to guideline implementation in treating intermediate- and high-risk PE and assesses catheter-based thrombectomy (CBT) as an alternative treatment. A single centre retrospective cohort study analyzed medical records of all PE-diagnoses between January 2022 and June 2023 . Patients with central, lobar, or segmental PE and Pulmonary Embolism Severity Index scores of III - V were included. A subgroup of patients received CBT. Data on patient characteristics, treatment, outcomes, and eligibility for CBT were collected. Of the 124 intermediate- and high-risk patients, thrombolysis was administered to only 17% of high-risk patients. Within the conventional treatment group, barriers to thrombolysis included contra-indications in 72% of intermediate-risk and 80% of high-risk patients, leaving a significant number eligible for CBT. Additionally, 20% of high-risk PE patients who did not received thrombolysis had no contra-indications and should have been treated with thrombolysis. In-hospital mortality was 50% among high-risk patients. Eleven patients received CBT, with no mortality at 30 days. Guideline-recommended thrombolysis is underutilized in high-risk PE, due to safety concerns and contra-indications. CBT demonstrates a promising alternative with a favourable safety profile and low mortality rates, highlighting the need for prospective studies. Multidisciplinary approaches, such as Pulmonary Embolism Response Teams, may help to standardize care and to improve outcomes.
- 4 May 2025
- Published by Taylor & Francis in Acta Clinica Belgica
- Vol. 80 (3) , 35-43
Barriers to guideline implementation in intermediate- and high-risk Pulmonary Embolism: insights from a real-world cohort study
Pulmonary embolism (PE) presents significant challenges due to its wide clinical spectrum, associated right ventricular failure, and high mortality rates. Despite guideline recommendations for systemic thrombolysis in high-risk PE, its implementation remains suboptimal due to safety concerns. This study investigates barriers to guideline implementation in treating intermediate- and high-risk PE and assesses catheter-based thrombectomy (CBT) as an alternative treatment. A single centre retrospective cohort study analyzed medical records of all PE-diagnoses between January 2022 and June 2023 . Patients with central, lobar, or segmental PE and Pulmonary Embolism Severity Index scores of III - V were included. A subgroup of patients received CBT. Data on patient characteristics, treatment, outcomes, and eligibility for CBT were collected. Of the 124 intermediate- and high-risk patients, thrombolysis was administered to only 17% of high-risk patients. Within the conventional treatment group, barriers to thrombolysis included contra-indications in 72% of intermediate-risk and 80% of high-risk patients, leaving a significant number eligible for CBT. Additionally, 20% of high-risk PE patients who did not received thrombolysis had no contra-indications and should have been treated with thrombolysis. In-hospital mortality was 50% among high-risk patients. Eleven patients received CBT, with no mortality at 30 days. Guideline-recommended thrombolysis is underutilized in high-risk PE, due to safety concerns and contra-indications. CBT demonstrates a promising alternative with a favourable safety profile and low mortality rates, highlighting the need for prospective studies. Multidisciplinary approaches, such as Pulmonary Embolism Response Teams, may help to standardize care and to improve outcomes.
- 10 December 2024
- Published by Wiley in Catheterization and Cardiovascular Interventions
- Vol. 105 (2) , 435-441
Gender‐Based Specificities of Fractional Flow Reserve Measurement
Background: The relationship between angiographic findings and fractional flow reserve (FFR) according to gender is currently unknown.Aims: To examine gender‐based differences in the concordance between angiographic and functional assessment of coronary stenosis severity.Methods: We examined 3770 coronary stenoses of stable patients undergoing both quantitative coronary angiography and FFR measurements in at least one coronary stenosis.Results: Median FFR values were higher in female as compared with male patients (0.84 vs. 0.81, p < 0.001) in the overall cohort and in the first three quartiles of diameter stenosis (DS). At receiver operator characteristics (ROC) analysis, DS was effective in predicting ischemic FFR values in both men and women. A 50% DS was the optimal cut off to identify functionally significant stenoses in the entire cohort and in male patients. In females, a higher DS threshold (≥ 59%) significantly improved lesions classification (69.4% vs. 72.4%, p = 0.034), yet at the cost of an increased false negatives rate (10.5% vs. 20.8%, p < 0.001). A lower cut‐off of 50% showed a superior diagnostic accuracy for ischemic FFR values (i.e., FFR values ≤ 0.80, AUC: 0.697 vs. 0.661, p = 0.006). Female gender was independently associated with a reduced risk of ischemic FFR (OR 0.51 95% CI [0.43−0.61]).Conclusions: Female patients show higher FFR values across different DS thresholds compared to male patients. A DS ≥ 50% is the best threshold to identify ischemic FFR in both males and females. A higher threshold of DS (≥ 59%) is associated with a significant improvement in lesion classification, despite leading to increased false negatives rate.
- 10 December 2024
- Published by Wiley in Catheterization and Cardiovascular Interventions
- Vol. 105 (2) , 435-441
Gender‐Based Specificities of Fractional Flow Reserve Measurement
Background: The relationship between angiographic findings and fractional flow reserve (FFR) according to gender is currently unknown.Aims: To examine gender‐based differences in the concordance between angiographic and functional assessment of coronary stenosis severity.Methods: We examined 3770 coronary stenoses of stable patients undergoing both quantitative coronary angiography and FFR measurements in at least one coronary stenosis.Results: Median FFR values were higher in female as compared with male patients (0.84 vs. 0.81, p < 0.001) in the overall cohort and in the first three quartiles of diameter stenosis (DS). At receiver operator characteristics (ROC) analysis, DS was effective in predicting ischemic FFR values in both men and women. A 50% DS was the optimal cut off to identify functionally significant stenoses in the entire cohort and in male patients. In females, a higher DS threshold (≥ 59%) significantly improved lesions classification (69.4% vs. 72.4%, p = 0.034), yet at the cost of an increased false negatives rate (10.5% vs. 20.8%, p < 0.001). A lower cut‐off of 50% showed a superior diagnostic accuracy for ischemic FFR values (i.e., FFR values ≤ 0.80, AUC: 0.697 vs. 0.661, p = 0.006). Female gender was independently associated with a reduced risk of ischemic FFR (OR 0.51 95% CI [0.43−0.61]).Conclusions: Female patients show higher FFR values across different DS thresholds compared to male patients. A DS ≥ 50% is the best threshold to identify ischemic FFR in both males and females. A higher threshold of DS (≥ 59%) is associated with a significant improvement in lesion classification, despite leading to increased false negatives rate.
- 6 December 2024
- Published by Wiley in Catheterization and Cardiovascular Interventions
- Vol. 105 (2) , 426-434
Impact of Robotic Percutaneous Coronary Intervention (R‐PCI) With and Without CCTA‐Guidance on Clinical Outcomes and Hospital Economics: A Single Center Registry
Background: Several studies have confirmed the safety and efficacy of robotic assisted coronary interventions for simple and complex coronary lesions. However, in the real‐world clinical setting the currently available evidence is still inconclusive with regard to clinical outcomes. In terms of financial sustainability, the emerging use of pre‐PCI Coronary Computed Tomography Angiography (CCTA) may potentially impact the overall patient journey and related costs. However, the role of CCTA guidance in elective robotic‐assisted revascularizations and its potential impact on hospital economics has never been investigated. Therefore, we aimed to assess the clinical impact of R‐PCI according to procedural complexity and its potential financial sustainability when integrated with CCTA guidance.Methods: Major adverse cardiovascular events (MACE) at the latest clinical follow‐up available have been prospectively evaluated in a single center cohort of 111 patients undergoing elective R‐PCI (CorPath, Corindus GRX Robotic Drive, Boston, MA). The study population was subsequently divided into two groups according to either the median Syntax Score (SS = 14) as a surrogate of procedural complexity or the adoption of CCTA‐guidance. Additionally, both periprocedural and in‐hospital outcomes have been investigated in the overall cohort and in the subgroups.Results: Overall, MACE occurred in 5.4% of the patients at a median follow‐up of 309 days. Procedural complexity was associated with significantly longer procedural time and radiation exposure (SS ≥ 14: 94.5 ± 32.1 vs. 78.7 ± 25.5 min, p = 0.011, and 32.7 ± 30.9 vs. 22.5 ± 19.8 mSv, p = 0.010, respectively), but not with increased in‐hospital and long‐term clinical outcomes. Additionally, patients undergoing CCTA‐guided R‐PCI had a significantly higher rate of same‐day‐discharge (SDD—64.6% vs. 44.2% respectively, p = 0.034) than those without CCTA support.Conclusion: R‐PCI appears safe and effective regardless the procedural complexity. Moreover, the integration of robotics and CCTA‐guidance appears to have beneficial impact on hospital economics by optimizing resource utilization and improving patient selection for percutaneous revascularization.
- 6 December 2024
- Published by Wiley in Catheterization and Cardiovascular Interventions
- Vol. 105 (2) , 426-434
Impact of Robotic Percutaneous Coronary Intervention (R‐PCI) With and Without CCTA‐Guidance on Clinical Outcomes and Hospital Economics: A Single Center Registry
Background: Several studies have confirmed the safety and efficacy of robotic assisted coronary interventions for simple and complex coronary lesions. However, in the real‐world clinical setting the currently available evidence is still inconclusive with regard to clinical outcomes. In terms of financial sustainability, the emerging use of pre‐PCI Coronary Computed Tomography Angiography (CCTA) may potentially impact the overall patient journey and related costs. However, the role of CCTA guidance in elective robotic‐assisted revascularizations and its potential impact on hospital economics has never been investigated. Therefore, we aimed to assess the clinical impact of R‐PCI according to procedural complexity and its potential financial sustainability when integrated with CCTA guidance.Methods: Major adverse cardiovascular events (MACE) at the latest clinical follow‐up available have been prospectively evaluated in a single center cohort of 111 patients undergoing elective R‐PCI (CorPath, Corindus GRX Robotic Drive, Boston, MA). The study population was subsequently divided into two groups according to either the median Syntax Score (SS = 14) as a surrogate of procedural complexity or the adoption of CCTA‐guidance. Additionally, both periprocedural and in‐hospital outcomes have been investigated in the overall cohort and in the subgroups.Results: Overall, MACE occurred in 5.4% of the patients at a median follow‐up of 309 days. Procedural complexity was associated with significantly longer procedural time and radiation exposure (SS ≥ 14: 94.5 ± 32.1 vs. 78.7 ± 25.5 min, p = 0.011, and 32.7 ± 30.9 vs. 22.5 ± 19.8 mSv, p = 0.010, respectively), but not with increased in‐hospital and long‐term clinical outcomes. Additionally, patients undergoing CCTA‐guided R‐PCI had a significantly higher rate of same‐day‐discharge (SDD—64.6% vs. 44.2% respectively, p = 0.034) than those without CCTA support.Conclusion: R‐PCI appears safe and effective regardless the procedural complexity. Moreover, the integration of robotics and CCTA‐guidance appears to have beneficial impact on hospital economics by optimizing resource utilization and improving patient selection for percutaneous revascularization.
- 10 October 2024
- Published by Elsevier in Journal of Cardiovascular Computed Tomography
- Vol. 19 (1) , 17-25
Improved diagnostic accuracy of vessel-specific myocardial ischemia by coronary computed tomography angiography (CCTA)
- 10 October 2024
- Published by Elsevier in Journal of Cardiovascular Computed Tomography
- Vol. 19 (1) , 17-25
Improved diagnostic accuracy of vessel-specific myocardial ischemia by coronary computed tomography angiography (CCTA)
- 21 January 2024
- Published by Elsevier in Journal of Cardiovascular Computed Tomography
- Vol. 18 (2) , 154-161
Predictors of percutaneous coronary intervention derived from CCTA in patients with chronic coronary syndrome
- 21 January 2024
- Published by Elsevier in Journal of Cardiovascular Computed Tomography
- Vol. 18 (2) , 154-161
Predictors of percutaneous coronary intervention derived from CCTA in patients with chronic coronary syndrome
- Open Access
- 6 December 2023
- Published by Radcliffe Medical Media Ltd in Interventional Cardiology: Reviews, Research, Resources
- Vol. 18, e30
Latest Developments in Robotic Percutaneous Coronary Interventions
Since the first robotic-assisted percutaneous coronary intervention procedure (R-PCI) was performed in 2004, there has been a steady evolution in robotic technology, combined with a growth in the number of robotic installations worldwide and operator experience. This review summarises the latest developments in R-PCI with a focus on developments in robotic technology, procedural complexity, tele-stenting and training methods, which have all contributed to the global expansion in R-PCI.
- 6 December 2023
- Published by Radcliffe Medical Media Ltd in Interventional Cardiology: Reviews, Research, Resources
- Vol. 18, e30
Open AccessLatest Developments in Robotic Percutaneous Coronary Interventions
Since the first robotic-assisted percutaneous coronary intervention procedure (R-PCI) was performed in 2004, there has been a steady evolution in robotic technology, combined with a growth in the number of robotic installations worldwide and operator experience. This review summarises the latest developments in R-PCI with a focus on developments in robotic technology, procedural complexity, tele-stenting and training methods, which have all contributed to the global expansion in R-PCI.
- 18 April 2023
- Published by Elsevier in Health Policy
- Vol. 132, 104826
Same Day Discharge Strategy by Default in a Tertiary Catheterization Laboratory in Belgium: Value Based Healthcare-Change in Practice
- 18 April 2023
- Published by Elsevier in Health Policy
- Vol. 132, 104826
Same Day Discharge Strategy by Default in a Tertiary Catheterization Laboratory in Belgium: Value Based Healthcare-Change in Practice